MoU28 Apr 2025, 12:07 pm
Sigachi Industries Limited Partners with Respilon Group s.r.o to Advance Nanofiber-Based Drug Delivery Technologies
AI Summary
Sigachi Industries Limited, a leading player in the pharmaceutical industry, has announced a partnership between its wholly owned subsidiary, Sigachi MENA FZCO, and Respilon Group s.r.o. The partnership aims to leverage Respilon’s NUENEX® nanofiber technology to transform patient experience and therapeutic outcomes through non-invasive, precision drug delivery. The MoU was signed on April 24, 2025, and the collaboration will focus on developing Invisible Patch and Powder-based pharmaceutical delivery formats.
Key Highlights
- Sigachi MENA FZCO has entered into a Memorandum of Understanding (MoU) with Respilon Group s.r.o.
- The partnership aims to leverage Respilon’s NUENEX® nanofiber technology for drug delivery solutions.
- The focus is on the development of Invisible Patch and Powder-based pharmaceutical delivery formats.
- The collaboration includes developing commercialization strategies for relevant APIs and formulations.
- NUENEX® technology offers a revolutionary approach to medication delivery through nanofiber encapsulation.